Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 29, 2013
Panel 6: VaccinesStephen I Pelton, Melinda M Pettigrew, Stephen J Barenkamp, et al.Expert Review of Vaccines|July 18, 2014
The mouse intranasal challenge model for potency testing of whole-cell pertussis vaccinesAnne Marie Queenan, Jeffrey Fernandez, Wenchi Shang, et al.Vaccines|January 28, 2026
The Bacterial Swiss Army Knife: ExPEC Utilizes Multiple Resistance Mechanisms to Counteract Host Immune ResponsesEveline Weerdenburg, Susan King, Joyce Lübbers, et al.Infection and Immunity|March 3, 2010
Interaction of pneumococcal histidine triad proteins with human complementMerit Melin, Emmanuel Di Paolo, Leena Tikkanen, et al.Vaccine|May 19, 2009
Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristicsJan Poolman, Pavla Kriz, Christiane Feron, et al.The Pediatric Infectious Disease Journal|October 16, 2010
Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccineTerry Nolan, Peter Richmond, Helen Marshall, et al.Vaccine|June 21, 2020
Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infectionsElie Saade, Stefan Gravenstein, Curtis J Donskey, et al.Pathogens (Basel, Switzerland)|April 28, 2023
Colonization with Escherichia coli ST131-H30R (H30R) Corresponds with Increased Serum Anti-O25 IgG Levels and Decreased TNFα and IL-10 Responsiveness to H30RBrian D Johnston, Connie Clabots, Tricia Bender, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 7, 2024
Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60-85 years in a randomized, double-blind, phase 1 studyMiwa Haranaka, Atsushi Momose, Yoshikazu Nakayama, et al.International Journal of Medical Microbiology : IJMM|December 25, 2015
Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cellsRodrigo Villarino Romero, Shakir Hasan, Kellen Faé, et al.Pageof 7